These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37847279)

  • 21. Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of SARS-CoV-2 infection: comment from Kell et al.
    Kell DB; Khan MA; Laubscher GJ; Pretorius E
    J Thromb Haemost; 2024 Feb; 22(2):565-568. PubMed ID: 38309813
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurologic and Neuromuscular Sequelae of COVID-19.
    Li C; Verduzco-Gutierrez M
    Phys Med Rehabil Clin N Am; 2023 Aug; 34(3):539-549. PubMed ID: 37419530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 Infection and Risk of Postacute Psychiatric and Neurologic Diagnoses: A Nationwide Danish Cohort Study.
    Nielsen NM; Spiliopoulos L; Hansen JV; Videbech P; Hviid A
    Neurology; 2024 Mar; 102(5):e208113. PubMed ID: 38382013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus methodology for the development of postacute sequelae of SARS-CoV-2 guidance statements.
    Maley JH; Sampsel S; Abramoff BA; Herman E; Neerukonda KV; Mikkelsen ME
    PM R; 2021 Sep; 13(9):1021-1026. PubMed ID: 34240583
    [No Abstract]   [Full Text] [Related]  

  • 25. Research progress of post-acute sequelae after SARS-CoV-2 infection.
    Jiao T; Huang Y; Sun H; Yang L
    Cell Death Dis; 2024 Apr; 15(4):257. PubMed ID: 38605011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further evidence from a large US electronic health record-based study that some children and adolescents can develop postacute sequelae of SARS-CoV-2 infection.
    Buonsenso D
    Evid Based Nurs; 2023 Jul; 26(3):97. PubMed ID: 36599668
    [No Abstract]   [Full Text] [Related]  

  • 27. Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review.
    Hirt J; Janiaud P; Gloy VL; Schandelmaier S; Pereira TV; Contopoulos-Ioannidis D; Goodman SN; Ioannidis J; Munkholm K; Hemkens LG
    Arch Dis Child; 2023 Jun; 108(6):498-505. PubMed ID: 36719840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies.
    Rahmati M; Yon DK; Lee SW; Udeh R; McEVoy M; Kim MS; Gyasi RM; Oh H; López Sánchez GF; Jacob L; Li Y; Koyanagi A; Shin JI; Smith L
    J Med Virol; 2023 Jun; 95(6):e28833. PubMed ID: 37264687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases.
    Patel NJ; Cook C; Vanni K; Fu X; Wang X; Kawano Y; Qian G; Hang B; Srivatsan S; Banasiak EP; Kowalski E; Bade K; Zhang Y; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2023 Apr; 82(4):565-573. PubMed ID: 36442978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences.
    Rahmati M; Udeh R; Yon DK; Lee SW; Dolja-Gore X; McEVoy M; Kenna T; Jacob L; López Sánchez GF; Koyanagi A; Shin JI; Smith L
    J Med Virol; 2023 Jun; 95(6):e28852. PubMed ID: 37288652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection.
    Mina Y; Enose-Akahata Y; Hammoud DA; Videckis AJ; Narpala SR; O'Connell SE; Carroll R; Lin BC; McMahan CC; Nair G; Reoma LB; McDermott AB; Walitt B; Jacobson S; Goldstein DS; Smith BR; Nath A
    Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37147136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram (From One, Many).
    Gross R; Lo Re V
    JAMA; 2023 Jun; 329(22):1918-1919. PubMed ID: 37227710
    [No Abstract]   [Full Text] [Related]  

  • 34. "Long Haulers".
    Lutchmansingh DD; Higuero Sevilla JP; Possick JD; Gulati M
    Semin Respir Crit Care Med; 2023 Feb; 44(1):130-142. PubMed ID: 36646091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study.
    Xie Y; Choi T; Al-Aly Z
    BMJ; 2023 Apr; 381():e074572. PubMed ID: 37161995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection.
    Durstenfeld MS; Peluso MJ; Kelly JD; Win S; Swaminathan S; Li D; Arechiga VM; Zepeda V; Sun K; Shao S; Hill C; Arreguin MI; Lu S; Hoh R; Tai V; Chenna A; Yee BC; Winslow JW; Petropoulos CJ; Kornak J; Henrich TJ; Martin JN; Deeks SG; Hsue PY
    JCI Insight; 2022 May; 7(10):. PubMed ID: 35389890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic and therapeutic management of medium and long-term sequelae of SARS-CoV-2 infection].
    Genecand L; Bridevaux PO; Garin N; Thonney J; Bonvin-Mullor N; Bouali R; Frésard I
    Rev Med Suisse; 2021 Apr; 17(736):842-849. PubMed ID: 33908722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae.
    Swank Z; Senussi Y; Manickas-Hill Z; Yu XG; Li JZ; Alter G; Walt DR
    Clin Infect Dis; 2023 Feb; 76(3):e487-e490. PubMed ID: 36052466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection.
    Kelesidis T; Mantzoros CS
    Metabolism; 2022 Sep; 134():155267. PubMed ID: 35901934
    [No Abstract]   [Full Text] [Related]  

  • 40. SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
    Cortellini A; Tabernero J; Mukherjee U; Salazar R; Sureda A; Maluquer C; Ferrante D; Bower M; Sharkey R; Mirallas O; Plaja A; Cucurull M; Mesia R; Dalla Pria A; Newsom-Davis T; Van Hemelrijck M; Sita-Lumsden A; Apthorp E; Vincenzi B; Di Fazio GR; Tonini G; Pantano F; Bertuzzi A; Rossi S; Brunet J; Lambertini M; Pedrazzoli P; Biello F; D'Avanzo F; Lee AJX; Shawe-Taylor M; Rogers L; Murphy C; Cooper L; Andaleeb R; Khalique S; Bawany S; Ahmed S; Carmona-García MC; Fort-Culillas R; Liñan R; Zoratto F; Rizzo G; Perachino M; Doonga K; Gaidano G; Bruna R; Patriarca A; Martinez-Vila C; Pérez Criado I; Giusti R; Mazzoni F; Antonuzzo L; Santoro A; Parisi A; Queirolo P; Aujayeb A; Rimassa L; Diamantis N; Bertulli R; Fulgenzi CAM; D'Alessio A; Ruiz-Camps I; Saoudi-Gonzalez N; Garcia Illescas D; Medina I; Fox L; Gennari A; Aguilar-Company J; Pinato DJ;
    Lancet Oncol; 2023 Apr; 24(4):335-346. PubMed ID: 36898391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.